Student Needlestick Policy
Student Percutaneous Injury/Bloodborne Pathogen Exposure Procedure
In case of needlestick or body fluid exposure* immediately:
1. Wash exposed area thoroughly with soap & water or appropriate tissue cleanser
2. Notify supervisor
3. Seek care within 2 hours of exposure; call first to expedite treatment
a. M-F 8:30 am – 4:30 pm: Student Health Clinic (210) 592-0150
b. After Hours: UHS Emergency Triage (210) 358-2488
4. Bring the following, or send to UTHSCSA Student Health Service
a. UTHSCSA Incident Report Form
b. TDH Contaminated Sharps Injury Reporting Form
c. Incident report from facility where exposure occurred
d. Identification of person whose body fluid was exposure source
e. Contact person for follow up
f. Relevant medical records
5. If exposure occurs outside the San Antonio area (more than 30-45 minutes away from the Health Science Center), go to the nearest ER or health care facility
a. Providers may consult the 24 hour national HIV Post-Exposure Prophylaxis Hotline for Clinicians at 1-888-HIV-4911
b. Call the Student Health Clinic at 592-0150 for follow up on the next non-holiday workday
6. Obtain consent of patient (source of exposure) for blood tests per facility protocol
a. Hepatitis B Surface Antigen (HBsAg)
b. Hepatitis C Antibody (Anti-HCV)
c. Antibody to Human Immunodeficiency virus (Anti-HIV)
7. Student blood to be drawn in Student Health Services as soon as possible for
b. Antibody to Hepatitis B Surface Antigen (Anti-HBs)**
c. Hepatitis C Antibody
e. omit HBsAg & Anti-HBs if the student has a documented seroconversion following a Hepatitis B vaccination series
* Injury must relate to currently registered UTHSCSA student’s clinical duties: percutaneous needlestick, puncture wound, laceration, human/animal bite; body fluid exposure to open wound or mucous membrane by splash, aerosol; other blood/unfixed tissue exposure
1. Hepatitis B
a. Patient HBsAg positive and student HBsAg negative and Anti-HBs negative:
- give one dose of Hepatitis B Immune Globulin (.06 ml/kg intramuscularly) as soon as possible within 72 hours after exposure, and begin a Hepatitis B vaccination series within seven days.
- a student with prior Hepatitis B vaccination with a negative Anti-HBs should receive HBIG and one dose of Hepatitis B vaccine.
b. No further Hepatitis B testing or therapy is needed if
- the patient (exposure source) is HBsAg negative
- the student is HBsAg positive or Anti-HBs positive due to prior disease or vaccination, even though the patient is HBsAg positive
2. Hepatitis C
a. Patient source is positive for Hepatitis C:
- test student for HCV-PCR 2-3 weeks after exposure
- test student for Hepatitis C serology at 6 weeks, 3 months, 6 months, & 1 year.
a. Risk of HIV transmission following percutaneous exposure to HIV-infected blood is approximately 0.3% (CDC, 2005).
b. Anti-HIV seroconversion in a needlestick recipient has been documented despite use
c. Drugs used for HIV prophylaxis have multiple potential side effects. Please contact
Student Health Service prior to discontinuing prophylaxis medications to ensure it is
indeed the medication responsible for the symptoms.
d. Students are responsible for costs of elective evaluation outside the Student Health Service.
1. Students at all sites receive, at no cost, testing, medication and follow up care per 2005 CDC guidelines
a. HIV: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5409a1.htm
b. Hepatitis B & C: http://www.cdc.gov/ncidod/dhqp/gl_occupational.html
2. A centralized service coordinate the testing and treatment of exposed students. The current requirement for students to pay for care, then file a claim with private insurance, with a UTHSCSA reimbursement limit of $500 should be deleted.